|
MAP3K13 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.159200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.904800E-01 |
| Normal-vs-Stage2 |
8.986600E-01 |
| Normal-vs-Stage3 |
2.951000E-01 |
| Normal-vs-Stage4 |
5.166400E-02 |
| Stage1-vs-Stage2 |
5.896400E-01 |
| Stage1-vs-Stage3 |
6.162200E-01 |
| Stage1-vs-Stage4 |
2.351200E-01 |
| Stage2-vs-Stage3 |
3.559800E-01 |
| Stage2-vs-Stage4 |
1.248050E-01 |
| Stage3-vs-Stage4 |
2.023200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.326600E-01 |
| Normal-vs-AfricanAmerican |
3.569200E-01 |
| Normal-vs-Asian |
8.75799999966453E-07 |
| Caucasian-vs-AfricanAmerican |
4.846800E-01 |
| Caucasian-vs-Asian |
4.10560474506383E-11 |
| AfricanAmerican-vs-Asian |
1.57329999994626E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.693200E-01 |
| Normal-vs-Female |
8.869400E-01 |
| Male-vs-Female |
3.670000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.738400E-01 |
| Normal-vs-Extreme_Weight |
9.415700E-02 |
| Normal-vs-Obese |
7.806000E-01 |
| Normal-vs-Extreme_Obese |
5.807200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.079400E-01 |
| Normal_Weight-vs-Obese |
3.276800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.455800E-01 |
| Extreme_Weight-vs-Obese |
2.546300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.244200E-01 |
| Obese-vs-Extreme_Obese |
5.724800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.582800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.100600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.270200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.893000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.567400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.605800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.908400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.886000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.947600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.747400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.718800E-01 |
| Normal-VS-Type2 PRCC |
7.660000E-01 |
| Normal-VS-KIRP CIMP |
7.038400E-02 |
| Normal-VS-Unclassified PRCC |
3.029400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.333600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.829900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.600970E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.807990E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.105400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.185800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.406000E-01 |
| Normal-vs-N1 |
3.316000E-01 |
| Normal-vs-N2 |
3.687200E-01 |
| N0-vs-N1 |
8.698200E-01 |
| N0-vs-N2 |
6.822400E-01 |
| N1-vs-N2 |
7.504000E-01 |
|
|
